Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Pharmacokinetic and Safety Trial Optimizing PreTerm Infant Ampicillin Dosing

NCT07610486 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT07610486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07610486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Pharmacokinetic and Safety Trial Optimizing PreTerm Infant Ampicillin Dosing
Lead sponsor
Duke University
Phase
Phase 1/2
Overall status
Recruiting
Start date
July 28, 2026
Completion date
December 31, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ampicillin, early onset sepsis, nicu, preterm neonates, safety and pharmacokinetics